Posted on October 22nd, 2009 by Kelley Luckstein
AssureRx, a personalized medicine company, announced today that it has begun a full launch of its first product, GeneSightRx(TM) This lab-developed, pharmacogenetic test had previously been commercially available only on a limited basis. The test combines state-of-the-art genetic testing technology with a multi-variate, algorithmic, interpretive report to help guide physicians during their decision-making process before prescribing psychiatric medications…
James S. Burns, President & CEO, commented, "The launch of GeneSightRx(TM) represents a major advance in the treatment of psychiatric disorders…GeneSightRx(TM) brings cutting-edge harmacogenetics technology developed at Mayo Clinic and Cincinnati Children's Hospital Medical Center into routine clinical use."
You must be logged-in to the site to post a comment.